Effects of purified puerarin on voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol

Journal of Medicinal Food

Volumn 7, Issue 2, 2004, Pages 180-186

  Benlhabib, Elhabib ^a   Baker, John I ^b   Keyler, Daniel E ^b,c   Singh, Ashok K ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alcohol withdrawal; Alcohol preferring rats; Blood brain barrier; High pressure liquid chromatography; Isoflavones; Kudzu root; NMDA and GABA; Opioid receptors; Puerarin

Indexed keywords

ALCOHOL; DAIDZIN; ISOFLAVONE; KUDZU ROOT EXTRACT; PLANT EXTRACT; PUERARIN; UNCLASSIFIED DRUG; WATER;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG LIVER LEVEL; DRUG MECHANISM; DRUG TISSUE LEVEL; FEMALE; FLUID INTAKE; FOOD INTAKE; HYPERSENSITIVITY; MOTOR COORDINATION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; TREMOR;

ALCOHOL DRINKING; ALCOHOLISM; ANIMALS; ANXIETY; BODY WEIGHT; DRINKING; FEMALE; ISOFLAVONES; PHYTOTHERAPY; RATS; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA; PUERARIA MONTANA VAR. LOBATA;

EID: 3042794172     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/1096620041224102     Document Type: Article

References (38)

1. Keung WM, Vallee BL: An ancient Chinese source of modern antidiposotropic agents. Phytochemistry 1998;47:499-506.
2. Benlhabib E, Baker JI, Keyler JE, Singh AK: Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 2004;7:168-179.
3. Lin RC, Guthrie S, Xie C-Y, Mai K, Lee DY, Lumeng L, Li T-K: Isoflavonoid compounds extracted from Pueraria lobata suppresses alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol Clin Exp Res 1996;20:659-663.
4. Keung WM, Vallee BL: Therapeutic lesions from traditional Oriental medicine to contemporary Occidental pharmacology. EXS 1994;71:371-381.
5. Keyler DE, Baker JI, Lee DY-W, Overstreet DH, Boucher TA, Lenz SK: Toxicity study of an antidipsotropic Chinese herbal mixture in rats: NPI-028. J Altern Complement Med 2002;8:175-183.
6. Shebek J, Rindone JP: A pilot study exploring the effects of kudzu root on drinking habits of patients with chronic alcoholism. J Altern Complement Med 2000;6:45-48.
7. Hunt WA: Neuroscience research: how has it contributed to our understanding of alcohol abuse and alcoholism? A review. Alcohol Clin Exp Res 1993;17:1055-1065.
8. Rice DP, Kelman S, Miller LS, Dunmeyer S: The Economic Cost to Society of Alcohol and Drug Abuse and Mental Illness, Washington, DC, Superintendent of Documents, U.S. Government Printing Office, 1993.
9. Benlhabib E, Baker J, Keyler D, Singh AK: Composition, RBC uptake, and serum protein binding of phytoestrogens extracted from commercial kudzu-root and soy preparations. J Med Food 2002;5:109-123.
10. Keung WM, Vallee BL: Daidzin and daidzein suppress free-choice ethanol intake by Syrian golden hamsters. Proc Natl Acad Sci U S A 1993;90:10008-10012.
11. Heyman GM, Keung WM, Vallee. BL: Daidzin decreases ethanol consumption in rats. Alcohol Clin Exp Res 1996;20:1083-1087.
12. Overstreet DH, Lee DY-W, Rezvani AH, Chriswell HE, Janowsky DS: Suppression of alcohol intake following administration of the Chinese herbal medicine, NPI-028 and its derivatives. Alcohol Clin Exp Res 1996;20:221-227.
13. Overstreet DH, Lee DY-W, Chen Y, Rezvani AH: The Chinese herbal medicine NPI-028 suppresses alcohol intake in alcohol preferring rats and monkeys without inducing taste aversion. Perfusion 1998;11:381-390.
14. Lumeng L, Li T-K: The development of metabolic tolerance in the alcohol preferring P rats: comparison of forced and free-choice drinking of ethanol. Pharmacol Biochem Behav 1986;25:1013-1020.
15. American Psychiatric Association: Diagnosis and Statistical Manual of Mental Disorders (DSM-IV), 4th ed., American Psychiatric Association, Washington DC, 1994.
16. Kampov-Povevoy AB, Matthews DB, Gause L, Morrow AL, Overstreet DH: P rats develop physiological dependence on alcohol via voluntary drinking: changes in seizure threshold, anxiety, and patterns of alcohol drinking. Alcohol Clin Exp Res 1000;24:278-284.
17. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT: CRG antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 1991;103:227-232.
18. File S, Baldwin HA, Hitchcott PK: Flumazenil but not nitrendipine reverses the increased anxiety in the rat. Psychopharmacology 1989;98:262-264.
19. Froehlich JC, Badia-Elder NE, Zink RW, McCullough DE, Portoghese PS: Contribution of the opioid system to alcohol averson and alcohol drinking behavior. J Pharmacol Exp Ther 1998;287:284-292.
20. Froehlich JC, Wand GS: The neurobiology of ethanol-opioid interaction in ethanol reinforcement. Alcohol Clin Exp Res 1997;20 (Suppl):181A-186A.
21. Hyytia P: Involvement of μ opioid receptors in alcohol drinking by alcohol preferring AA rats. Pharmacol Biochem Behav 1993;45:697-701.
22. Koob GF, Bloom FE: Cellular and molecular mechanisms of drug dependence. Science 1988;242:715-723.
23. Koob GF, Le Moal M: Drug abuse: hedonic homeostatic dysregulation. Science 1997;278:52-58.
24. Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, Hyytia P, Merlo-Pich E, Weiss F: Neurocircuitry targets in ethanol reward and dependence. Alcohol Clin Exp Res 1988;22:3-9.
25. Pandey S, Saito T, Yoshimura M, Sohma H, Gotz ME: cAMP signaling cascade: a promising role in ethanol tolerance and dependence. Alcohol Clin Exp Res 2001;25 (Suppl):46S-48S.
26. Froehlich JC, Harts J, Lumeng L, Li T-K: Naloxone attenuates voluntary ethanol intake in rats selectively bred for high ethanol preference. Pharmacol Biochem Behav 1991;35:385-390.
27. Jones EA, Dekker LR: Florid opioid withdrawal-like reaction precipitated by naltrexone in a patient with chronic cholestasis. Gastroenterology 2000;118:431-432.
28. O'Malley SS, Krishnan-Sarin S, Farren C, O'Connor OG: Naltrexone-induced nausea in patients treated for alcohol dependence: clinical predictors and evidence for opioid-mediated effects. J Clin Psychopharmacol 2000;20:69-76.
29. Oncken C, Van Kirk J, Kranzler HR: Adverse effects of oral naltrexone: analysis of data from two clinical trials. Psychopharmacology 2001;154:397-402.
30. 2C agonists. Pharmacol Biochem Behav 2002;75:619-625.
31. Qian Y, Li Z, Huang L, Han X, Sun J, Zhou H, Liu Z: Blocking effect of puerarin on calcium channel in isolated guinea pig ventricular myocytes. Chin Med J 1999;112:787-789.
32. Lian Z, Niwa K, Tagami K, Hashimoto M, Gao J, Yokoyama Y, Mori H, Tamaya T: Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice. Jpn J Cancer Res 2001;92:726-734.
33. Dong LP, Wang TY: Effects of puerarin against glutamate excitotoxicity on cultured mouse cerebral cortical neurons. Acta Pharmacol Sinica 1998;19:339-342.
34. Choi JH, Chung WJ, Han SJ, Lee HB, Choi IW, Lee HK, Jang KY, Lee DG, Han SS, Park KH, IM SY: Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. Inflammation 2000;24:385-398.
35. Rooke N, Li DJ, Li J, Keung WM: The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin. J Med Chem 2000;43:4169-4179.
36. Gao GY, Li DJ, Keung WM: Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway. J Med Chem 2001;44:3320-3328.
37. Sheikh S, Weiner H: Allosteric inhibition of human liver aldehyde dehydrogenase by the isoflavone prunetin. Biochem Pharmacol 1997;53:471-478.
38. Lin RC, Li TK: Effects of isoflavones on alcohol pharmacokinetics and alcohol-drinking behavior in rats. Am J Clin Nutr 1998;68(Suppl):1512S-1515S.